| Structure |
Chemical Name |
CAS |
MF |
 |
Ponatinib |
943319-70-8 |
C29H27F3N6O |
 |
2-METHOXYESTRADIOL |
362-07-2 |
C19H26O3 |
 |
Vadimezan |
117570-53-3 |
C17H14O4 |
 |
Roxadustat |
808118-40-3 |
C19H16N2O5 |
 |
R-406 |
841290-80-0 |
C22H23FN6O5 |
 |
PD 173074 |
219580-11-7 |
C28H41N7O3 |
 |
Infigratinib |
872511-34-7 |
C26H31Cl2N7O3 |
 |
PF-562271 |
717907-75-0 |
C21H20F3N7O3S |
![N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea](/CAS2/GIF/950769-58-1.gif) |
N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea |
950769-58-1 |
C29H32N6O4S |
 |
Dovitinib |
405169-16-6 |
C21H21FN6O |
 |
PF 573228 |
869288-64-2 |
C22H20F3N5O3S |
 |
GNF-2 |
778270-11-4 |
C18H13F3N4O2 |
 |
AZD-4547 |
1035270-39-3 |
C26H33N5O3 |
 |
Fostamatinib |
901119-35-5 |
C23H26FN6O9P |
 |
IOX2 |
931398-72-0 |
C19H16N2O5 |
 |
PP2 |
172889-27-9 |
C15H16ClN5 |
 |
PP1 |
172889-26-8 |
C16H19N5 |
 |
WH-4-023 |
837422-57-8 |
C32H36N6O4 |
 |
KX2-391 |
897016-82-9 |
C26H29N3O3 |
![L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2)](/CAS/GIF/685898-44-6.gif) |
L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2) |
685898-44-6 |
C13H19Cl3N2O3 |
 |
PRT062607 (Hydrochloride) |
1370261-97-4 |
C19H24ClN9O |
 |
RN486 |
1242156-23-5 |
C35H35FN6O3 |
 |
CNX-774 |
1202759-32-7 |
C26H22FN7O3 |
 |
TCS 359 |
301305-73-7 |
C18H20N2O4S |
![6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine](/CAS2/GIF/934353-76-1.gif) |
6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine |
934353-76-1 |
C21H25N7 |
 |
Debio-1347 |
1265229-25-1 |
C20H16N6O |
 |
PF-562271 |
939791-38-5 |
C27H26F3N7O6S2 |
 |
BAY 87-2243 |
1227158-85-1 |
C26H26F3N7O2 |
 |
R788(Fostamatinib disodium) |
1025687-58-4 |
C23H27FN6NaO9P |
 |
TAE226 (NVP-TAE226) |
761437-28-9 |
C23H25ClN6O3 |
 |
PF-562271HCl |
|
C21H21ClF3N7O3S |
![N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide](/CAS2/GIF/717906-29-1.gif) |
N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide |
717906-29-1 |
C22H21F3N6O3S |
 |
R406 |
841290-81-1 |
C28H29FN6O8S |
 |
GNF5 |
778277-15-9 |
C20H17F3N4O3 |
![N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea](/CAS/GIF/1020172-07-9.gif) |
N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea |
1020172-07-9 |
C30H28FN7O3 |
 |
Dovitinib Dilactic acid (TKI258 Dilactic acid) |
852433-84-2 |
C24H27FN6O4 |
 |
LFM-A13 |
244240-24-2 |
C11H8Br2N2O2 |
 |
G-749 |
1457983-28-6 |
C25H25BrN6O2 |
![[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone](/CAS/GIF/1000669-72-6.gif) |
[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone |
1000669-72-6 |
C20H20N4O |
 |
GSK 2830371 |
1404456-53-6 |
C23H29ClN4O2S |
 |
PD173955 |
260415-63-2 |
C21H16Cl2N4OS |
![N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(tert-butyl)benzamide](/CAS/GIF/910232-84-7.gif) |
N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(tert-butyl)benzamide |
910232-84-7 |
C34H37N5O4 |
 |
WP1130 |
856243-80-6 |
C19H18BrN3O |
 |
FGFR inhibitor |
848318-25-2 |
C18H15N2NaO4 |
 |
GZD824 |
1421783-64-3 |
C31H35F3N6O7S2 |
 |
Defactinib |
1073154-85-4 |
C20H21F3N8O3S |
 |
Plinabulin(NPI-2358) |
714272-27-2 |
C19H20N4O2 |
|
|
ENMD-2076 (Tartrate) |
1291074-87-7 |
C21H25N7.x(C4H6O6) |
 |
Entospletinib (GS-9973) |
1229208-44-9 |
C23H21N7O |